Clinical Trial Update: First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line capecitabine plus cetuximab in elderly patients with metastatic colorectal cancer. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED